Skip to main content
Top
Published in: European Radiology 3/2015

01-03-2015 | Breast

Dixon imaging-based partial volume correction improves quantification of choline detected by breast 3D-MRSI

Authors: Lenka Minarikova, Stephan Gruber, Wolfgang Bogner, Katja Pinker-Domenig, Pascal A. T. Baltzer, Thomas H. Helbich, Siegfried Trattnig, Marek Chmelik

Published in: European Radiology | Issue 3/2015

Login to get access

Abstract

Objectives

Our aim was to develop a partial volume (PV) correction method of choline (Cho) signals detected by breast 3D-magnetic resonance spectroscopic imaging (3D-MRSI), using information from water/fat-Dixon MRI.

Methods

Following institutional review board approval, five breast cancer patients were measured at 3 T. 3D-MRSI (1 cm3 resolution, duration ~11 min) and Dixon MRI (1 mm3, ~2 min) were measured in vivo and in phantoms. Glandular/lesion tissue was segmented from water/fat-Dixon MRI and transformed to match the resolution of 3D-MRSI. The resulting PV values were used to correct Cho signals. Our method was validated on a two-compartment phantom (choline/water and oil). PV values were correlated with the spectroscopic water signal. Cho signal variability, caused by partial-water/fat content, was tested in 3D-MRSI voxels located in/near malignant lesions.

Results

Phantom measurements showed good correlation (r = 0.99) with quantified 3D-MRSI water signals, and better homogeneity after correction. The dependence of the quantified Cho signal on the water/fat voxel composition was significantly (p < 0.05) reduced using Dixon MRI-based PV correction, compared to the original uncorrected data (1.60-fold to 3.12-fold) in patients.

Conclusions

The proposed method allows quantification of the Cho signal in glandular/lesion tissue independent of water/fat composition in breast 3D-MRSI. This can improve the reproducibility of breast 3D-MRSI, particularly important for therapy monitoring.

Key Points

Choline signal in breast spectroscopic imaging can be corrected using Dixon MRI.
Partial volume-matched MRI provides comparable information with quantified 3D-MRSI water signal.
Corrected breast 3D-MRSI could improve reproducibility for follow-up studies and inter-subject comparison.
Literature
1.
go back to reference Kvistad KA, Bakken IJ, Gribbestad IS et al (1999) Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 10:159–164CrossRefPubMed Kvistad KA, Bakken IJ, Gribbestad IS et al (1999) Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 10:159–164CrossRefPubMed
2.
go back to reference Baltzer PA, Dietzel M (2013) Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T–systematic review and meta-analysis. Radiology 267:735–746CrossRefPubMed Baltzer PA, Dietzel M (2013) Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T–systematic review and meta-analysis. Radiology 267:735–746CrossRefPubMed
3.
go back to reference Meisamy S, Bolan PJ, Baker EH et al (2005) Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology 236:465–475CrossRefPubMed Meisamy S, Bolan PJ, Baker EH et al (2005) Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology 236:465–475CrossRefPubMed
4.
go back to reference Gruber S, Debski BK, Pinker K et al (2011) Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions. Radiology 261:752–761CrossRefPubMed Gruber S, Debski BK, Pinker K et al (2011) Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions. Radiology 261:752–761CrossRefPubMed
5.
go back to reference Pinker K, Bogner W, Baltzer P et al (2014) Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging. Investig Radiol. doi:10.1097/RLI.0000000000000029 Pinker K, Bogner W, Baltzer P et al (2014) Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging. Investig Radiol. doi:10.​1097/​RLI.​0000000000000029​
6.
go back to reference Jagannathan NR, Kumar M, Seenu V et al (2001) Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84:1016–1022CrossRefPubMedCentralPubMed Jagannathan NR, Kumar M, Seenu V et al (2001) Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84:1016–1022CrossRefPubMedCentralPubMed
7.
go back to reference Baek HM, Chen JH, Nalcioglu O, Su MY (2008) Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy. Ann Oncol 19:1022–1024CrossRefPubMedCentralPubMed Baek HM, Chen JH, Nalcioglu O, Su MY (2008) Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy. Ann Oncol 19:1022–1024CrossRefPubMedCentralPubMed
8.
go back to reference Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE (2001) The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 68:45–54CrossRefPubMed Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE (2001) The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 68:45–54CrossRefPubMed
9.
go back to reference Yeung DK, Cheung HS, Tse GM (2001) Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy—initial results. Radiology 220:40–46CrossRefPubMed Yeung DK, Cheung HS, Tse GM (2001) Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy—initial results. Radiology 220:40–46CrossRefPubMed
10.
go back to reference Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE (1998) Human breast lesions: characterization with proton MR spectroscopy. Radiology 209:269–275CrossRefPubMed Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE (1998) Human breast lesions: characterization with proton MR spectroscopy. Radiology 209:269–275CrossRefPubMed
11.
go back to reference Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA (2004) Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 19:68–75CrossRefPubMed Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA (2004) Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 19:68–75CrossRefPubMed
12.
go back to reference Bolan PJ, Meisamy S, Baker EH et al (2003) In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 50:1134–1143CrossRefPubMed Bolan PJ, Meisamy S, Baker EH et al (2003) In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 50:1134–1143CrossRefPubMed
13.
go back to reference Murphy PS, Leach MO, Rowland IJ (1999) Signal modulation in (1)H magnetic resonance spectroscopy using contrast agents: proton relaxivities of choline, creatine, and N-acetylaspartate. Magn Reson Med 42:1155–1158CrossRefPubMed Murphy PS, Leach MO, Rowland IJ (1999) Signal modulation in (1)H magnetic resonance spectroscopy using contrast agents: proton relaxivities of choline, creatine, and N-acetylaspartate. Magn Reson Med 42:1155–1158CrossRefPubMed
14.
go back to reference Baltzer PA, Gussew A, Dietzel M et al (2012) Effect of contrast agent on the results of in vivo (1)H MRS of breast tumors - is it clinically significant? NMR Biomed 25:67–74CrossRefPubMed Baltzer PA, Gussew A, Dietzel M et al (2012) Effect of contrast agent on the results of in vivo (1)H MRS of breast tumors - is it clinically significant? NMR Biomed 25:67–74CrossRefPubMed
15.
go back to reference Dorrius MD, Pijnappel RM, van der Weide Jansen MC et al (2012) The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging. Eur Radiol 22:915–922CrossRefPubMedCentralPubMed Dorrius MD, Pijnappel RM, van der Weide Jansen MC et al (2012) The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging. Eur Radiol 22:915–922CrossRefPubMedCentralPubMed
16.
go back to reference Gasparovic C, Song T, Devier D et al (2006) Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 55:1219–1226CrossRefPubMed Gasparovic C, Song T, Devier D et al (2006) Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 55:1219–1226CrossRefPubMed
18.
go back to reference Clendenen TV, Zeleniuch-Jacquotte A, Moy L, Pike MC, Rusinek H, Kim S (2013) Comparison of 3-point dixon imaging and fuzzy C-means clustering methods for breast density measurement. J Magn Reson Imaging. doi:10.1002/jmri.24002 PubMed Clendenen TV, Zeleniuch-Jacquotte A, Moy L, Pike MC, Rusinek H, Kim S (2013) Comparison of 3-point dixon imaging and fuzzy C-means clustering methods for breast density measurement. J Magn Reson Imaging. doi:10.​1002/​jmri.​24002 PubMed
19.
go back to reference Graham SJ, Stanchev PL, Lloyd-Smith JO, Bronskill MJ, Plewes DB (1995) Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging 5:695–701CrossRefPubMed Graham SJ, Stanchev PL, Lloyd-Smith JO, Bronskill MJ, Plewes DB (1995) Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging 5:695–701CrossRefPubMed
20.
go back to reference Bartella L, Thakur SB, Morris EA et al (2007) Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology 245:80–87CrossRefPubMed Bartella L, Thakur SB, Morris EA et al (2007) Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology 245:80–87CrossRefPubMed
21.
go back to reference Baek HM, Chen JH, Yu HJ, Mehta R, Nalcioglu O, Su MY (2008) Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging 27:1114–1121CrossRefPubMed Baek HM, Chen JH, Yu HJ, Mehta R, Nalcioglu O, Su MY (2008) Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging 27:1114–1121CrossRefPubMed
22.
go back to reference Danishad KK, Sharma U, Sah RG, Seenu V, Parshad R, Jagannathan NR (2010) Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI). NMR Biomed 23:233–241PubMed Danishad KK, Sharma U, Sah RG, Seenu V, Parshad R, Jagannathan NR (2010) Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI). NMR Biomed 23:233–241PubMed
23.
go back to reference Meyer CR, Bland PH, Pipe J (1995) Retrospective correction of intensity inhomogeneities in MRI. IEEE Trans Med Imaging 14:36–41CrossRefPubMed Meyer CR, Bland PH, Pipe J (1995) Retrospective correction of intensity inhomogeneities in MRI. IEEE Trans Med Imaging 14:36–41CrossRefPubMed
24.
go back to reference Bolan PJ, Henry PG, Baker EH, Meisamy S, Garwood M (2004) Measurement and correction of respiration-induced B0 variations in breast 1H MRS at 4 Tesla. Magn Reson Med 52:1239–1245CrossRefPubMed Bolan PJ, Henry PG, Baker EH, Meisamy S, Garwood M (2004) Measurement and correction of respiration-induced B0 variations in breast 1H MRS at 4 Tesla. Magn Reson Med 52:1239–1245CrossRefPubMed
Metadata
Title
Dixon imaging-based partial volume correction improves quantification of choline detected by breast 3D-MRSI
Authors
Lenka Minarikova
Stephan Gruber
Wolfgang Bogner
Katja Pinker-Domenig
Pascal A. T. Baltzer
Thomas H. Helbich
Siegfried Trattnig
Marek Chmelik
Publication date
01-03-2015
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 3/2015
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3425-1

Other articles of this Issue 3/2015

European Radiology 3/2015 Go to the issue